Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.28 EUR -3.45% Market Closed
Market Cap: 18.2m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Net Margin
Biotechnology Assets SA

-99.9%
Current
-36%
Average
-7.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-99.9%
=
Net Income
-3.1m
/
Revenue
3.1m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
ES
Biotechnology Assets SA
MAD:BST
17.8m EUR
-100%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
314.9B USD
9%
US
Amgen Inc
NASDAQ:AMGN
140.6B USD
13%
US
Gilead Sciences Inc
NASDAQ:GILD
115.7B USD
0%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.9B USD
-5%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
135.7B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.8B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
36B EUR
-14%
Country ES
Market Cap 17.8m EUR
Net Margin
-100%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 314.9B USD
Net Margin
9%
Country US
Market Cap 140.6B USD
Net Margin
13%
Country US
Market Cap 115.7B USD
Net Margin
0%
Country US
Market Cap 103.9B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 135.7B AUD
Net Margin
18%
Country US
Market Cap 77.8B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 36B EUR
Net Margin
-14%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
17.8m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Undervaluation 2%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-99.9%
=
Net Income
-3.1m
/
Revenue
3.1m
What is the Net Margin of Biotechnology Assets SA?

Based on Biotechnology Assets SA's most recent financial statements, the company has Net Margin of -99.9%.